Losartan potassium 50mg

DRUG4 trials

Sponsors

Chinese PLA General Hospital, Centro Neurológico de Pesquisa e Reabiitação, Brazil, University of Oxford

Conditions

Blood PressureEmotional ProcessingGlomerulonephritisHypertensionProteinuriaSocial Cognition

Early Phase 1

Matão Controlling Hypertension (MatCH Study): Rationale and Design

Centro Neurológico de Pesquisa e Reabiitação, BrazilBlood Pressure, Hypertension

Start: 2018-02-01End: 2021-06-30Target: 15000Updated: 2017-11-21

Losartan and Social Processing

RecruitingNCT06624904

University of OxfordSocial Cognition

Start: 2024-08-19End: 2025-10-01Target: 68Updated: 2025-07-28

Losartan and Emotional Learning

RecruitingNCT06628154

University of OxfordEmotional Processing

Start: 2024-08-14End: 2025-07-31Target: 60Updated: 2024-10-04

Phase 4

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

Chinese PLA General HospitalGlomerulonephritis, Proteinuria

Start: 2014-02-28Target: 720Updated: 2015-07-01

Related Papers

Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial

Journal of Integrative Medicine2021-01-305 citations

P0394EFFICACY AND SAFETY OF A CHINESE PATENT MEDICINE-SHENYANKANGFU TABLETS FOR PRIMARY GLOMERULONEPHRITIS:A RANDOMISED CONTROLLED TRIAL

Nephrology Dialysis Transplantation2020-06-01

Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.

2014-12-057 citations